Alessa Therapeutics ("Alessa"), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...

As per DelveInsight estimates, the total prevalent population of prostate cancer in the 7MM was nearly 8,241,000 cases in 2023. These cases are projected to increase during the forecast period, i.e., ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Ground-breaking new research has found for the first time that the friendly bacteria in the gut can be enhanced to help slow ...

Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Parabilis Medicines is taking an early lead in the 2026 biotech fundraising race, closing a $305 million series F round that ...

About Flare Therapeutics Inc. Flare Therapeutics is a clinical-stage biotechnology company exclusively focused on drugging transcription factors to fully unlock the therapeutic potential of this ...

The exact cause of PCOS is unknown, but it is common to see it in women with a family history of PCOS, insulin resistance, or metabolic syndrome. Due to insulin resistance being linked to obesity, ...

Hair loss among women in their 20s and 30s is increasingly linked to hormonal disorders like PCOS and PCOD. Here is more on it ...

Hair loss has always been emotionally loaded, but the science behind it is becoming unusually exciting. A wave of new drugs, ...

In long-term survivors of cancer, socioeconomic vulnerability and having multiple comorbidities are associated with a risk of ...